HMNC Brain Health Initiates Pioneering Precision Therapy Program in Mental Health
September 16, 2021 08:30 ET
|
HMNC Brain Health
Pioneering the first large-scale double-blind studies to test the combination of therapies and genetic companion diagnostics in the area of mental healthPartners with worldwide leading contract...
HMNC Brain Health to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 08:30 ET
|
HMNC Brain Health
MUNICH, Germany, Sept. 07, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company pioneering the development of personalized therapies powered by...
HMNC Brain Health and Develco Pharma Partner to Initiate Ketamine Study Targeting Treatment-Resistant Depression (TRD)
August 24, 2021 08:30 ET
|
HMNC Brain Health
MUNICH, Germany, Aug. 24, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company pioneering the development of personalized therapies powered by...
HMNC Brain Health Raises EUR 9 Million
July 28, 2021 11:34 ET
|
HMNC Brain Health
MUNICH, Germany, July 28, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “Company”), a biotech company pioneering the development of personalized therapies in psychiatry powered by...